Hetero Labs, Ltd. - Unit III FDA Record
- No warning letters matched by name
Hetero Labs, Ltd. - Unit III has 5 FDA recalls, 0 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Hetero Labs, Ltd. - Unit III" is on file.
- Latest recall
- D-1211-2018 · Class III · Sep 12, 2018
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 5 | Nov 15, 2026 | File dated Nov 10, 2026 | Current |
| 510(k) clearances | 0 | Nov 15, 2026 | File dated Nov 9, 2026 | Current |
| Inspections | 0 | Nov 17, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
Hetero Labs, Ltd. - Unit III: FDA recall records per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 3 | 0 |
| 2017 | 0 | 0 | 0 | 2 | 0 |
Reviewing Hetero Labs, Ltd. - Unit III as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Hetero Labs, Ltd. - Unit III yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1211-2018 | Class III | Fenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only, Manufactured for: Camber… | Sep 12, 2018 |
| D-1019-2018 | Class II | Indomethacin Capsules, USP, 50 mg, 100-count bottles, Rx only, Manufactured for: Camber… | Jul 18, 2018 |
| D-0594-2018 | Class II | Aripiprazole Tablets, USP, 10 mg, 30-count bottles, Rx Only, Manufactured for Camber… | Jan 10, 2018 |
| D-0223-2018 | Class III | Simvastatin Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: Camber… | Dec 22, 2017 |
| D-0099-2018 | Class II | Levetiracetam Oral Solution, USP, 100 mg/mL, packaged in a 16 fl oz (473 mL) bottle, Rx only… | Oct 12, 2017 |
Hetero Labs, Ltd. - Unit III and the FDA: common questions
Has Hetero Labs, Ltd. - Unit III received an FDA warning letter?
No FDA warning letter addressed to the name "Hetero Labs, Ltd. - Unit III" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Hetero Labs, Ltd. - Unit III received an FDA Form 483?
FDA has not published a Form 483 for "Hetero Labs, Ltd. - Unit III" in its reading room. FDA publishes some Form 483s, not all of them.
Has Hetero Labs, Ltd. - Unit III had an FDA recall?
Yes. Hetero Labs, Ltd. - Unit III has 5 FDA recalls on record. The most recent started Sep 12, 2018.
Need more than this page shows? Ask about Hetero Labs, Ltd. - Unit III in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.